Trial Profile
An Open-label, Randomized, Single-dose Crossover Study to Compare the Pharmacokinetics After the Administration of HCP1201 Tablet 750/10 mg and Coadministration of Metformin SR 750 mg and Rosuvastatin 10 mg in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 May 2014
Price :
$35
*
At a glance
- Drugs Metformin/rosuvastatin (Primary) ; Metformin; Rosuvastatin
- Indications Hyperlipidaemia; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Hanmi Pharmaceutical
- 10 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jan 2014 New trial record